THE EFFECT OF ANTIDIABETIC AGENT GLIBENCLAMIDE AND MELTFORMINE ON LIPIDS AND GLYCATEDHAEMOGLOBIN IN TYPE 2 DIABETES PATIENT ATTENDING UITH ILORIN.DOCX

Showing the single result